Fact CheckerSign in

NCT07818538Active, not recruiting

OCCUPATIONAL THERAPY INTERVENTIONS ON COGNITIVE PERFORMANCE IN CHILDREN WITH AUTISM SPECTRUM DISORDER

THE EFFECT OF VIRTUAL REALITY-SUPPORTED OCCUPATIONAL THERAPY INTERVENTIONS ON COGNITIVE PERFORMANCE IN CHILDREN WITH AUTISM SPECTRUM DISORDER

Source: ClinicalTrials.gov · Last updated 14 Sept 2026

Brief summary (registry, in English)

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by deficits in social communication and interaction, as well as restricted and repetitive patterns of behavior. Children with ASD may experience difficulties in attention, working memory, planning, cognitive flexibility, problem-solving, and executive functions. The aim of this study is to investigate the effects of virtual reality-supported cognitive-focused occupational therapy on cognitive performance, occupational performance, and motivation in children with ASD. A total of 32 children with ASD aged 6-12 years will be assigned to either the intervention group (n=16) or the control group (n=16). The intervention group will receive virtual reality-supported cognitive-focused occupational therapy for 40 minutes once a week for 8 weeks, while the control group will receive structured occupational therapy sessions with the same frequency and duration. Cognitive performance, occupational performance, and motivation will be assessed using the Dynamic Loewenstein Occupational Therapy Cognitive Assessment (DLOTCA), the Canadian Occupational Performance Measure (COPM), and the Pediatric Motivation Scale (PMS), respectively.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
32 (actual)
First submitted
8 Sept 2026
Start date
27 Aug 2026
Primary completion date
26 Oct 2026
Lead sponsor
Biruni University
Diseases
Autism
NCT number
NCT07818538

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 27 Aug 2026 to the primary completion date, 26 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of epilepsy. Presence of vestibular system disorders or complaints of vertigo. Presence of severe cardiovascular disorders. Inability to use the virtual reality application due to severe visual impairment.
  • Diagnosis of a severe neurological or psychiatric disorder other than Autism Spectrum Disorder.
  • Having a condition that may require medical treatment or a different intervention during the study period.

Other

  • Inability to understand the virtual reality experience or appropriately follow instructions.
  • Demonstrating difficulties in cooperation at a level that prevents the implementation of the SmartPose system.

Who the study is looking for

  • Aged between 6 and 12 years. Diagnosed with Autism Spectrum Disorder (ASD) Level 1 according to DSM-5 diagnostic criteria.
  • Able to stand and ambulate independently. Able to follow basic instructions and interact within a virtual environment. Voluntary participation of the child and/or legal guardian in the study and provision of written informed consent.

Age in the registry: 6 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istanbul Medipol University
Coordinator of this site? Confirm its status
KadıköyTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.